{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:04:56Z","timestamp":1788267896347,"version":"build-2803163510"},"reference-count":186,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Urological malignancies, including prostate, bladder, and renal cancers, remain a major clinical challenge because of tumor heterogeneity, disease progression, and therapeutic resistance. In this context, RNA methylation has emerged as an important post-transcriptional regulatory layer in cancer biology. Importantly, the biological consequences of RNA methylation are not dictated by chemical modifications alone, but by coordinated networks of regulatory proteins that install, remove, and interpret these marks, thereby shaping RNA fate and gene expression programs. Among currently studied RNA modifications, N\n                    <jats:sup>6<\/jats:sup>\n                    -methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) provides the most mature mechanistic framework, whereas non-m\n                    <jats:sup>6<\/jats:sup>\n                    A regulators remain comparatively less well characterized. In this review, we systematically summarize the regulatory logic underlying RNA methylation-mediated control in urological cancers, with particular emphasis on how distinct classes of regulatory proteins influence RNA stability, translation, metabolism, and other post-transcriptional processes. We further integrate current evidence across multiple RNA methylation types, including m\n                    <jats:sup>6<\/jats:sup>\n                    A, 5-methylcytosine (m\n                    <jats:sup>5<\/jats:sup>\n                    C), N\n                    <jats:sup>1<\/jats:sup>\n                    -methyladenosine (m\n                    <jats:sup>1<\/jats:sup>\n                    A), and N\n                    <jats:sup>7<\/jats:sup>\n                    -methylguanosine (m\n                    <jats:sup>7<\/jats:sup>\n                    G), while highlighting the relative immaturity of non-m\n                    <jats:sup>6<\/jats:sup>\n                    A evidence in these malignancies. We also provide an overview of current m\n                    <jats:sup>6<\/jats:sup>\n                    A detection technologies and discuss their methodological strengths, limitations, and appropriate research applications. Beyond mechanistic insights, we discuss the emerging clinical relevance of RNA methylation regulators in urological malignancies, particularly in relation to diagnostic-related evidence, prognostic stratification, immune-related relevance, and treatment-associated adaptation. In addition, we summarize current therapeutic efforts targeting RNA methylation pathways, including small-molecule inhibitors and related translational strategies, while emphasizing their present limitations. Overall, current evidence supports RNA methylation as a biologically important and increasingly translationally relevant framework in urological cancers, but not yet as a clinically mature one.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1790638","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:04:51Z","timestamp":1776769491000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["RNA methylation in urological cancers: regulatory logic, biological functions, and clinical relevance"],"prefix":"10.3389","volume":"17","author":[{"given":"Jiahao","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Urology, Jiangling People's Hospital","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangmin","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Nanchang University","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Qingdao Municipal Hospital","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuowei","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longwei","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpan","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuran","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangheng","family":"Tao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine, Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Zhongnan Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Urology, Jingzhou Hospital Affiliated to Yangtze University","place":["Jingzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","article-title":"European association of urology guidelines on renal cell carcinoma: the 2019 update","volume":"75","author":"Ljungberg","year":"2019","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.11.018","article-title":"A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer","volume":"7","author":"Slevin","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.06.029","article-title":"Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy","volume":"58","author":"Kaag","year":"2010","journal-title":"Eur Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25043","article-title":"Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3323","article-title":"Targeting PD-1 or PD-L1 in metastatic kidney cancer: combination therapy in the first-line setting","volume":"26","author":"Aggen","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000506296","article-title":"Association between PD-L1 expression and the prognosis and clinicopathologic features of renal cell carcinoma: A systematic review and meta-analysis","volume":"104","author":"Shen","year":"2020","journal-title":"Urol Int"},{"key":"B12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40164-022-00298-7","article-title":"Role of m6A writers, erasers and readers in cancer","volume":"11","author":"Fang","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/167483a0","article-title":"Nucleoside-5\u2032-phosphates from ribonucleic acid","volume":"167","author":"Cohn","year":"1951","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tips.2023.11.002","article-title":"The rise of epitranscriptomics: recent developments and future directions","volume":"45","author":"Cerneckis","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.687","article-title":"N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat Chem Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature16998","article-title":"The dynamic N1-methyladenosine methylome in eukaryotic messenger RNA","volume":"530","author":"Dominissini","year":"2016","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13804","article-title":"The dual role of N6-methyladenosine modification of RNAs is involved in human cancers","volume":"22","author":"He","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.11.022","article-title":"Epigenetic Regulation of m6A Modifications in Human Cancer","volume":"19","author":"Zhao","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00774-x","article-title":"The roles and implications of RNA m6A modification in cancer","volume":"20","author":"Deng","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-052521-035330","article-title":"The proteins of mRNA modification: writers, readers, and erasers","volume":"92","author":"Flamand","year":"2023","journal-title":"Annu Rev Biochem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-024-01777-5","article-title":"RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy","volume":"9","author":"Liu","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-100616-060758","article-title":"Rethinking m6A readers, writers, and erasers","volume":"33","author":"Meyer","year":"2017","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nsmb.3162","article-title":"N6-methyladenosine\u2013encoded epitranscriptomics","volume":"23","author":"Liu","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2019.02.008","article-title":"Regulation of gene expression by N6-methyladenosine in cancer","volume":"29","author":"Liu","year":"2019","journal-title":"Trends Cell Biol"},{"key":"B29","article-title":"Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase","volume":"3","author":"Bokar","year":"1997","journal-title":"RNA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2018.06.017","article-title":"N1-methyladenosine methylome in messenger RNA and non-coding RNA","volume":"45","author":"Xiong","year":"2018","journal-title":"Curr Opin Chem Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-023-00622-x","article-title":"Regulation and functions of non-m6A mRNA modifications","volume":"24","author":"Sun","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2014.151","article-title":"FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis","volume":"24","author":"Zhao","year":"2014","journal-title":"Cell Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","article-title":"Zc3h13 regulates nuclear RNA m6A methylation and mouse embryonic stem cell self-renewal","volume":"69","author":"Wen","year":"2018","journal-title":"Mol Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat Chem Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.05.048","article-title":"Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2019 sites","volume":"8","author":"Schwartz","year":"2014","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31311","article-title":"YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs","volume":"6","author":"Roundtree","year":"2017","journal-title":"Elife"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/life15121888","article-title":"Advances in quantitative techniques for mapping RNA modifications","volume":"15","author":"Tian","year":"2025","journal-title":"Life"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1392159","article-title":"Current progress in strategies to profile transcriptomic m6A modifications","volume":"12","author":"Yang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf895","article-title":"Toward standardized epitranscriptome analytics: an inter-laboratory comparison of mass spectrometric detection and quantification of modified ribonucleosides in human RNA","volume":"53","author":"Hengesbach","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3\u2032 UTRs and near Stop Codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1038\/s41598-020-63355-3","article-title":"Limits in the detection of m6A changes using MeRIP\/m6A-seq","volume":"10","author":"McIntyre","year":"2020","journal-title":"Sci Rep"},{"key":"B46","first-page":"2024.02.04.578119","article-title":"Identification of differentially methylated single-nucleotide m6 A sites by incorporating site-specific antibody specificity","volume-title":"Bioinformatics","author":"Guo","year":"2024"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0570-0","article-title":"DART-seq: an antibody-free method for global m6A detection","volume":"16","author":"Meyer","year":"2019","journal-title":"Nat Methods"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-022-00765-9","article-title":"m6A-SAC-seq for quantitative whole transcriptome m6A profiling","volume":"18","author":"Ge","year":"2023","journal-title":"Nat Protoc"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-023-00937-1","article-title":"GLORI for absolute quantification of transcriptome-wide m6A at single-base resolution","volume":"19","author":"Shen","year":"2024","journal-title":"Nat Protoc"},{"key":"B50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1261\/rna.072785.119","article-title":"Direct RNA sequencing enables m6 A detection in endogenous transcript isoforms at base-specific resolution","volume":"26","author":"Lorenz","year":"2020","journal-title":"RNA"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1101\/gr.278960.124","article-title":"Detecting m6A RNA modification from nanopore sequencing using a semisupervised learning framework","volume":"34","author":"Teng","year":"2024","journal-title":"Genome Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/s41467-023-37596-5","article-title":"Systematic comparison of tools used for m6A mapping from nanopore direct RNA sequencing","volume":"14","author":"Zhong","year":"2023","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.119651","article-title":"Comprehensive analysis of aberrant m6A RNA modifications identifies prognostic biomarkers in non-small cell lung cancer","volume":"22","author":"Li","year":"2025","journal-title":"Int J Med Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.molcel.2021.12.038","article-title":"scDART-seq reveals distinct m6A signatures and mRNA methylation heterogeneity in single cells","volume":"82","author":"Tegowski","year":"2022","journal-title":"Mol Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2024.2315385","article-title":"Single-cell analysis of the epitranscriptome: RNA modifications under the microscope","volume":"21","author":"Crespo-Garc\u00eda","year":"2024","journal-title":"RNA Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41467-023-35958-7","article-title":"scm6A-seq reveals single-cell landscapes of the dynamic m6A during oocyte maturation and early embryonic development","volume":"14","author":"Yao","year":"2023","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/and.14422","article-title":"METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner","volume":"54","author":"Wang","year":"2022","journal-title":"Andrologia"},{"key":"B58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3892\/ijo.2022.5464","article-title":"N6-methyladenosine-induced long non-coding RNA PVT1 regulates the miR-27b-3p\/BLM axis to promote prostate cancer progression","volume":"62","author":"Chen","year":"2023","journal-title":"Int J Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203541","article-title":"METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d","volume":"13","author":"Ma","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.77133","article-title":"M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy","volume":"19","author":"Zhong","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s11658-024-00628-z","article-title":"METTL3-mediated m6A modification of circGLIS3 promotes prostate cancer progression and represents a potential target for ARSI therapy","volume":"29","author":"Cheng","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-023-00650-x","article-title":"m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1","volume":"30","author":"Huang","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113149","article-title":"METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1\/c-Myc axis","volume":"416","author":"Liu","year":"2022","journal-title":"Exp Cell Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.426","article-title":"m6 A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization","volume":"11","author":"Lang","year":"2021","journal-title":"Clin Transl Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1177\/09636897221122997","article-title":"METTL3-mediated m6A modification of lncRNA MALAT1 facilitates prostate cancer growth by activation of PI3K\/AKT signaling","volume":"31","author":"Mao","year":"2022","journal-title":"Cell Transplant"},{"key":"B66","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12943-020-01267-6","article-title":"YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.7150\/jca.42338","article-title":"The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation","volume":"11","author":"Yuan","year":"2020","journal-title":"J Cancer"},{"key":"B68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41420-022-00939-0","article-title":"METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discov"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.21037\/tau-23-682","article-title":"METTL14 inhibits the proliferation, migration and invasion of prostate cancer cells by increasing m6A methylation of CDK4","volume":"13","author":"Zhong","year":"2024","journal-title":"Transl Androl Urol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.24976\/Discov.Med.202436180.5","article-title":"ALKBH5 suppresses autophagy in prostate cancer cells via inhibiting m6A-modification of TSPAN1 mRNA","volume":"36","author":"Zhao","year":"2024","journal-title":"Discov Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.34133\/research.0313","article-title":"The FTO mediated N6-methyladenosine modification of DDIT4 regulation with tumorigenesis and metastasis in prostate cancer","volume":"7","author":"Zhao","year":"2024","journal-title":"Res (Wash D C)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2001936","article-title":"Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R)","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"key":"B73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41420-022-01003-7","article-title":"N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability","volume":"8","author":"Zou","year":"2022","journal-title":"Cell Death Discov"},{"key":"B74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/1541-7786.MCR-22-0271","article-title":"m6A-Mediated biogenesis of circDDIT4 inhibits prostate cancer progression by sequestrating ELAVL1\/HuR","volume":"21","author":"Kong","year":"2023","journal-title":"Mol Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108586","article-title":"LXA4 enhances prostate cancer progression by facilitating M2 macrophage polarization via inhibition of METTL3","volume":"107","author":"Jia","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13046-022-02391-5","article-title":"circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA","volume":"41","author":"Ding","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01994-0","article-title":"Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer","volume":"23","author":"Ying","year":"2024","journal-title":"Mol Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05023-y","article-title":"METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms","volume":"479","author":"He","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01480-x","article-title":"Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p","volume":"21","author":"Yu","year":"2022","journal-title":"Mol Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s13258-021-01175-z","article-title":"YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44","volume":"43","author":"Li","year":"2021","journal-title":"Genes Genomics"},{"key":"B81","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13046-020-01735-3","article-title":"Activation of the KDM5A\/miRNA-495\/YTHDF2\/m6A-MOB3B axis facilitates prostate cancer progression","volume":"39","author":"Du","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01533-5","article-title":"RNA N6-methyladenosine-modified-binding protein YTHDF1 promotes prostate cancer progression by regulating androgen function-related gene TRIM68","volume":"28","author":"Nie","year":"2023","journal-title":"Eur J Med Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"16","DOI":"10.7150\/ijbs.75063","article-title":"ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner","volume":"18","author":"Li","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23365","article-title":"Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"B85","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-019-1036-9","article-title":"METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner","volume":"18","author":"Han","year":"2019","journal-title":"Mol Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215615","article-title":"Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer","volume":"534","author":"Yan","year":"2022","journal-title":"Cancer Lett"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0683-z","article-title":"The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-\u03baB\/MYC signaling network","volume":"38","author":"Cheng","year":"2019","journal-title":"Oncogene"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8849218","article-title":"The m6A methylation-regulated AFF4 promotes self-renewal of bladder cancer stem cells","volume":"2020","author":"Gao","year":"2020","journal-title":"Stem Cells Int"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15063","article-title":"METTL3\/YTHDF2 m6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer","volume":"24","author":"Xie","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0755-0","article-title":"Dynamic m6A mRNA methylation reveals the role of METTL3-m6A-CDCP1 signaling axis in chemical carcinogenesis","volume":"38","author":"Yang","year":"2019","journal-title":"Oncogene"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217002","article-title":"N6-methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination","volume":"595","author":"Shen","year":"2024","journal-title":"Cancer Lett"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.627706","article-title":"Deficiency of Mettl3 in bladder cancer stem cells inhibits bladder cancer progression and angiogenesis","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12943-019-1084-1","article-title":"Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6-methyladenosine of Notch1","volume":"18","author":"Gu","year":"2019","journal-title":"Mol Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04805-0","article-title":"PIGT promotes cell growth, glycolysis, and metastasis in bladder cancer by modulating GLUT1 glycosylation and membrane trafficking","volume":"22","author":"Tan","year":"2024","journal-title":"J Transl Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-023-01817-5","article-title":"m6A writer WTAP targets NRF2 to accelerate bladder cancer Malignancy via m6A-dependent ferroptosis regulation","volume":"28","author":"Wang","year":"2023","journal-title":"Apoptosis"},{"key":"B96","doi-asserted-by":"publisher","first-page":"5","DOI":"10.14670\/HH-18-671","article-title":"WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer","volume":"39","author":"Wang","year":"2024","journal-title":"Histol Histopathol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41388-023-02814-3","article-title":"M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription","volume":"42","author":"Xie","year":"2023","journal-title":"Oncogene"},{"key":"B98","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41420-021-00724-5","article-title":"FTO promotes tumour proliferation in bladder cancer via the FTO\/miR-576\/CDK6 axis in an m6A-dependent manner","volume":"7","author":"Zhou","year":"2021","journal-title":"Cell Death Discov"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.310","article-title":"FTO modifies the m6A level of MALAT and promotes bladder cancer progression","volume":"11","author":"Tao","year":"2021","journal-title":"Clin Transl Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202359","article-title":"Dysregulation of USP18\/FTO\/PYCR1 signaling network promotes bladder cancer development and progression","volume":"13","author":"Song","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10875-6","article-title":"m6A-YTHDF1 mediated regulation of GRIN2D in bladder cancer progression and aerobic glycolysis","volume":"63","author":"Le","year":"2024","journal-title":"Biochem Genet"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086905","article-title":"YTHDF1 promotes bladder cancer cell proliferation via the METTL3\/YTHDF1-RPN2-PI3K\/AKT\/mTOR axis","volume":"24","author":"Zhu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.24976\/Discov.Med.202436186.138","article-title":"Knockdown of YAP1 reduces YTHDF3 to stabilize SMAD7 and thus inhibit bladder cancer stem cell stemness","volume":"36","author":"Qiu","year":"2024","journal-title":"Discov Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010114","article-title":"m6A methylation-mediated stabilization of LINC01106 suppresses bladder cancer progression by regulating the miR-3148\/DAB1 axis","volume":"12","author":"Liu","year":"2024","journal-title":"Biomedicines"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16003","article-title":"IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK\/STAT signalling pathway in human bladder cancer","volume":"24","author":"Huang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12943-021-01359-x","article-title":"CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression","volume":"20","author":"Xie","year":"2021","journal-title":"Mol Cancer"},{"key":"B107","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12967-022-03496-3","article-title":"The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma","volume":"20","author":"Zhu","year":"2022","journal-title":"J Transl Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1159\/000540483","article-title":"METTL3 and IGF2BP1-mediated m6A modification of ZHX2 promotes tumor property of renal cell carcinoma","volume":"49","author":"Xiao","year":"2024","journal-title":"Kidney Blood Press Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101003","article-title":"CircPTEN suppresses human clear cell renal carcinoma progression and resistance to mTOR inhibitors by targeting epigenetic modification","volume":"71","author":"Zhan","year":"2023","journal-title":"Drug Resist Update"},{"key":"B110","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1172\/JCI179560","article-title":"VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas","volume":"134","author":"Lee","year":"2024","journal-title":"J Clin Invest"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.12.024","article-title":"METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination","volume":"27","author":"Shen","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15212","article-title":"Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1","volume":"113","author":"Liu","year":"2022","journal-title":"Cancer Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12964-022-00831-5","article-title":"METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma","volume":"20","author":"Liu","year":"2022","journal-title":"Cell Commun Signal"},{"key":"B114","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41416-022-01757-y","article-title":"METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma","volume":"127","author":"Zhang","year":"2022","journal-title":"Br J Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"646","DOI":"10.21037\/atm-20-3079","article-title":"ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann Transl Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14128","article-title":"N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1\u03b1 signalling axis","volume":"23","author":"Zhuang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.77774","article-title":"FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability","volume":"18","author":"Xu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06090-7","article-title":"The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling","volume":"14","author":"Shi","year":"2023","journal-title":"Cell Death Dis"},{"key":"B119","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41420-022-01151-w","article-title":"FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway","volume":"8","author":"Shen","year":"2022","journal-title":"Cell Death Discov"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14591","article-title":"N6-methyladenosine (m6A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis","volume":"11","author":"Yuan","year":"2023","journal-title":"PeerJ"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.994","article-title":"Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA","volume":"12","author":"Pan","year":"2022","journal-title":"Clin Transl Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.641833","article-title":"N6-methyladenosine modification of LncRNA DUXAP9 promotes renal cancer cells proliferation and motility by activating the PI3K\/AKT signaling pathway","volume":"11","author":"Tan","year":"2021","journal-title":"Front Oncol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41419-021-03489-y","article-title":"LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the Malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription","volume":"12","author":"Xie","year":"2021","journal-title":"Cell Death Dis"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1619","article-title":"DMDRMR-mediated regulation of m6A-modified CDK4 by m6A reader IGF2BP3 drives ccRCC progression","volume":"81","author":"Gu","year":"2021","journal-title":"Cancer Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03173-5","article-title":"LncRNA AGAP2 antisense RNA 1 stabilized by insulin-like growth factor 2 mRNA binding protein 3 promotes macrophage M2 polarization in clear cell renal cell carcinoma through regulation of the microRNA-9-5p\/THBS2\/PI3K-Akt pathway","volume":"23","author":"Xu","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1512","article-title":"circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma","volume":"13","author":"Liu","year":"2023","journal-title":"Clin Transl Med"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4157","article-title":"MicroRNA-501-3p inhibits the proliferation of kidney cancer cells by targeting WTAP","volume":"10","author":"He","year":"2021","journal-title":"Cancer Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41419-021-04038-3","article-title":"EGR2-mediated regulation of m6A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization","volume":"12","author":"Ying","year":"2021","journal-title":"Cell Death Dis"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.795611","article-title":"m6A-mRNA methylation regulates gene expression and programmable m6A modification of cellular RNAs with CRISPR-Cas13b in renal cell carcinoma","volume":"12","author":"Gan","year":"2021","journal-title":"Front Genet"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110217","article-title":"MiR-155 regulates m6A level and cell progression by targeting FTO in clear cell renal cell carcinoma","volume":"91","author":"Yang","year":"2022","journal-title":"Cell Signal"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-023-01223-z","article-title":"CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA","volume":"30","author":"Zhang","year":"2023","journal-title":"Cell Death Differ"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01809-8","article-title":"METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer","volume":"22","author":"Garc\u0131\u0301a-V\u0131\u0301lchez","year":"2023","journal-title":"Mol Cancer"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02777-z","article-title":"P300\/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC","volume":"42","author":"Zhang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1334112","article-title":"Depletion of the m1A writer TRMT6\/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer","volume":"13","author":"Monshaugen","year":"2023","journal-title":"Front Oncol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05661-y","article-title":"m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer Malignancy through facilitating RABL6\/TK1 mRNAs splicing and stabilization","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.675","article-title":"METTL1-m7 G-EGFR\/EFEMP1 axis promotes the bladder cancer development","volume":"11","author":"Ying","year":"2021","journal-title":"Clin Transl Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1192495","article-title":"The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Pharmacol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16023","article-title":"The current landscape of m6A modification in urological cancers","volume":"11","author":"Zeng","year":"2023","journal-title":"PeerJ"},{"key":"B139","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12935-022-02456-7","article-title":"Comprehensive analysis of N6-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer","volume":"22","author":"Cui","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112015","article-title":"m6A RNA methylation regulators correlate with Malignant progression and have potential predictive values in clear cell renal cell carcinoma","volume":"392","author":"Zhang","year":"2020","journal-title":"Exp Cell Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.831162","article-title":"Construction of a comprehensive diagnostic scoring model for prostate cancer based on a novel six-gene panel","volume":"13","author":"Liu","year":"2022","journal-title":"Front Genet"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.4103\/aja202265","article-title":"Research progress of m6A methylation in prostate cancer","volume":"25","author":"Zhang","year":"2023","journal-title":"Asian J Androl"},{"key":"B143","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.bbcan.2023.188961","article-title":"RNA m6A modification in prostate cancer: A new weapon for its diagnosis and therapy","volume":"1878","author":"Han","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-023-00851-x","article-title":"RNA N6-methyladenosine modifications in urological cancers: From mechanism to application","volume":"21","author":"Yang","year":"2024","journal-title":"Nat Rev Urol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9554","article-title":"Relationship between the genetic expression of WTAP and bladder cancer and patient prognosis","volume":"16","author":"Chen","year":"2018","journal-title":"Oncol Lett"},{"key":"B146","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/CU9.0000000000000135","article-title":"Dysregulation and implications of N6-methyladenosine modification in renal cell carcinoma","volume":"17","author":"Wu","year":"2023","journal-title":"Curr Urol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.737498","article-title":"The RNA N6-methyladenosine methyltransferase METTL3 promotes the progression of kidney cancer via N6-methyladenosine-dependent translational enhancement of ABCD1","volume":"9","author":"Shi","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21726","article-title":"The M6A methyltransferase METTL3: Acting as a tumor suppressor in renal cell carcinoma","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00003","article-title":"Effect of m6A RNA methylation regulators on Malignant progression and prognosis in renal clear cell carcinoma","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7524","article-title":"N6-methyladenosine RNA methylation regulators participate in Malignant progression and have prognostic value in clear cell renal cell carcinoma","volume":"43","author":"Zheng","year":"2020","journal-title":"Oncol Rep"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.124214","article-title":"Loss of UFL1 confers enzalutamide resistance of prostate tumors by regulating METTL16-mediated m6A modification of EEF1A1 mRNA","volume":"22","author":"Wu","year":"2026","journal-title":"Int J Biol Sci"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123646","article-title":"N6-methyladenosine-modified circQKI inhibits prostate cancer docetaxel-sensitivity via miR-188-3p\/Beclin-1 pathway","volume":"372","author":"Zhao","year":"2025","journal-title":"Life Sci"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116903","article-title":"N6-methyladenosine-modified RNF220 induces cisplatin resistance and immune escape via regulating PDE10A K48-linked ubiquitination in bladder cancer","volume":"236","author":"Li","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218282","article-title":"Lactylation enhances YTHDF3 stability to promote cisplatin resistance via m6A-dependent KDM6B decay in bladder cancer","volume":"642","author":"Yu","year":"2026","journal-title":"Cancer Lett"},{"key":"B155","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.omtn.2020.10.031","article-title":"ALKBH5 inhibited cell proliferation and sensitized bladder cancer cells to cisplatin by m6A-CK2\u03b1-mediated glycolysis","volume":"23","author":"Yu","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.34133\/research.0970","article-title":"Hypoxia-induced histone lactylation drives cisplatin resistance in bladder cancer by promoting RBM15-dependent m6 A methylation of IGFBP3","volume":"8","author":"Sun","year":"2025","journal-title":"Research"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202509654","article-title":"ER\u03b2\/circAHNAK axis inhibits USP10\u2013FMR1 deubiquitination to prevent m6A\u2010mediated ADAM17 decay and promote angiogenesis in clear cell renal cell carcinoma","volume":"12","author":"Xu","year":"2025","journal-title":"Adv Sci"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-025-01634-7","article-title":"CDK13 drives clear cell renal carcinoma through METTL16-mediated m6A modification of ACLY mRNA","volume":"58","author":"Chen","year":"2026","journal-title":"Exp Mol Med"},{"key":"B159","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13046-022-02460-9","article-title":"YTHDC1 is downregulated by the YY1\/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway","volume":"41","author":"Li","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1518","article-title":"Circ0008399 interaction with WTAP promotes assembly and activity of the m6A methyltransferase complex and promotes cisplatin resistance in bladder cancer","volume":"81","author":"Wei","year":"2021","journal-title":"Cancer Res"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13404","article-title":"YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer","volume":"56","author":"Su","year":"2023","journal-title":"Cell Prolif"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113520","article-title":"ALKBH5-IGF2BP2 axis mediates prostate cancer progression and docetaxel resistance via m6A-stabilized CLSPN RNA","volume":"28","author":"Chen","year":"2025","journal-title":"iScience"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117553","article-title":"LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1","volume":"243","author":"Tang","year":"2026","journal-title":"Biochem Pharmacol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0572-6","article-title":"Programmable m6A modification of cellular RNAs with a Cas13-directed methyltransferase","volume":"38","author":"Wilson","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.11.012","article-title":"Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up","volume":"34","author":"Balar","year":"2023","journal-title":"Ann Oncol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103972","article-title":"Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial","volume":"9","author":"Rosenberg","year":"2024","journal-title":"ESMO Open"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0499","article-title":"Tumor microenvironment dynamics in clear-cell renal cell carcinoma","volume":"9","author":"Vuong","year":"2019","journal-title":"Cancer Discov"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2024.12.003","article-title":"Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer","volume":"36","author":"Brea","year":"2025","journal-title":"Trends Endocrinol Metab"},{"key":"B169","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","article-title":"The role of RNA methylation in tumor immunity and its potential in immunotherapy","volume":"23","author":"Li","year":"2024","journal-title":"Mol Cancer"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.7150\/jca.99483","article-title":"Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"J Cancer"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037590","article-title":"ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment","volume":"103","author":"Pan","year":"2024","journal-title":"Medicine"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.735170","article-title":"Characterization of the m6A-associated tumor immune microenvironment in prostate cancer to aid immunotherapy","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.642159","article-title":"RNA modification of N6-methyladenosine predicts immune phenotypes and therapeutic opportunities in kidney renal clear cell carcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1323","article-title":"JNK signaling promotes bladder cancer immune escape by regulating METTL3-mediated m6A modification of PD-L1 mRNA","volume":"82","author":"Ni","year":"2022","journal-title":"Cancer Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011108","article-title":"METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5\/CCL5 regulation","volume":"13","author":"Tong","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-2485","article-title":"The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I\u2013mediated immune response","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15745","article-title":"HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer","volume":"114","author":"Cheng","year":"2023","journal-title":"Cancer Sci"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: The cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101848","article-title":"Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy","volume":"71","author":"Moussion","year":"2024","journal-title":"Semin Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1014861","article-title":"m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent","volume":"13","author":"Kong","year":"2022","journal-title":"Front Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001646","article-title":"m6 A modification patterns and tumor immune landscape in clear cell renal carcinoma","volume":"9","author":"Zhong","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1607222","article-title":"Gene signature for response prediction to immunotherapy and prognostic markers in metastatic urothelial carcinoma","volume":"16","author":"Langfelder","year":"2025","journal-title":"Front Immunol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01487-9","article-title":"Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI","volume":"41","author":"Liu","year":"2023","journal-title":"Nat Biotechnol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-022-30299-3","article-title":"Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches","volume":"13","author":"Lee","year":"2022","journal-title":"Nat Commun"},{"key":"B186","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41419-025-08180-0","article-title":"The emerging role of dendritic cells in the tumor microenvironment: from antigen presentation to targeted immunotherapy","volume":"16","author":"Xie","year":"2025","journal-title":"Cell Death Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1790638\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:04:53Z","timestamp":1776769493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1790638\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":186,"alternative-id":["10.3389\/fimmu.2026.1790638"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1790638","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1790638"}}